Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
    February 2024
  1. HE MM, Wang K, Lo CH, Zhang Y, et al
    Post-diagnostic multivitamin supplement use and colorectal cancer survival: A prospective cohort study.
    Cancer. 2024 Feb 6. doi: 10.1002/cncr.35234.
    >> Share

    January 2024
  2. BYRD DA, Zouiouich S, Karwa S, Li XS, et al
    Associations of serum trimethylamine N-oxide and its precursors with colorectal cancer risk in the Prostate, Lung, Colorectal, Ovarian Cancer Screening Trial Cohort.
    Cancer. 2024 Jan 29. doi: 10.1002/cncr.35219.
    >> Share

  3. CAAN BJ, Brown JC, Lee C, Binder AM, et al
    Effect of home-based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer: The FORCE randomized control trial.
    Cancer. 2024 Jan 24. doi: 10.1002/cncr.35204.
    >> Share

  4. HALF EE, Levi Z, Mannalithara A, Leshno M, et al
    Colorectal cancer screening at age 45 years in Israel: Cost-effectiveness and global implications.
    Cancer. 2024 Jan 5. doi: 10.1002/cncr.35097.
    >> Share

  5. BYTNAR JA, McGlynn KA, Nealeigh MD, Shriver CD, et al
    Cancer incidence in the US military: An updated analysis.
    Cancer. 2024;130:96-106.
    >> Share

    December 2023
  6. AREVALO M, Sutton SK, Abdulla R, Christy SM, et al
    Longitudinal adherence to annual colorectal cancer screening among Black persons living in the United States enrolled in a community-based randomized trial.
    Cancer. 2023 Dec 27. doi: 10.1002/cncr.35169.
    >> Share

  7. EOM KY, Koroukian SM, Dong W, Kim U, et al
    Accounting for Medicaid expansion and regional policy and programs to advance equity in cancer prevention in the United States.
    Cancer. 2023;129:3915-3927.
    >> Share

    November 2023
  8. YANG K, Doege D, Thong MSY, Koch-Gallenkamp L, et al
    Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study.
    Cancer. 2023 Nov 23. doi: 10.1002/cncr.35133.
    >> Share

    October 2023
  9. MAHAR AL, Biggs K, Hansford RL, Derksen S, et al
    Stage IV breast, colorectal, and lung cancer at diagnosis in adults living with intellectual or developmental disabilities: A population-based cross-sectional study.
    Cancer. 2023 Oct 30. doi: 10.1002/cncr.35068.
    >> Share

  10. HSU HY, Chern YJ, Hsu MS, Yeh TL, et al
    Diabetic severity and oncological outcomes of colorectal cancer following curative resection: A population-based cohort study in Taiwan diabetes and colorectal cancer prognosis.
    Cancer. 2023 Oct 23. doi: 10.1002/cncr.34975.
    >> Share

  11. VAN TUIJL LA, Basten M, Pan KY, Vermeulen R, et al
    Depression, anxiety, and the risk of cancer: An individual participant data meta-analysis.
    Cancer. 2023;129:3287-3299.
    >> Share

  12. TAMMEMAGI MC, Cina K, Kitts AKB, Koop D, et al
    Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self-reporting as Indigenous and non-Indigenous.
    Cancer. 2023 Oct 9. doi: 10.1002/cncr.34947.
    >> Share

    September 2023
  13. RIEDINGER CJ, Esnakula A, Haight PJ, Suarez AA, et al
    Characterization of mismatch-repair (MMR)/microsatellite instability (MSI)-discordant endometrial cancers.
    Cancer. 2023 Sep 26. doi: 10.1002/cncr.35030.
    >> Share

  14. MALCOMSON FC, Wiggins C, Parra-Soto S, Ho FK, et al
    Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and cancer risk: A systematic review and meta-analysis.
    Cancer. 2023;129:2655-2670.
    >> Share

    August 2023
  15. BROWN JC, Ma C, Shi Q, Zemla T, et al
    Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance).
    Cancer. 2023 Aug 31. doi: 10.1002/cncr.35007.
    >> Share

  16. TRILLA-FUERTES L, Gamez-Pozo A, Nogue M, Busquier I, et al
    Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
    Cancer. 2023;129:2581-2592.
    >> Share

  17. ISLAMI F, Wiese D, Marlow EC, Kratzer TB, et al
    Progress in reducing cancer mortality in the United States by congressional district, 1996-2003 to 2012-2020.
    Cancer. 2023;129:2522-2531.
    >> Share

    June 2023
    New standard of care for refractory metastatic colorectal cancer.
    Cancer. 2023;129:1789-1790.
    >> Share

  19. MOORADIAN MJ, Cleary JM, Giobbie-Hurder A, Darville LNF, et al
    Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors.
    Cancer. 2023;129:1904-1918.
    >> Share

    May 2023
  20. SPENCER JC, Noel L, Shokar NK, Pignone MP, et al
    Understanding the role of access in Hispanic cancer screening disparities.
    Cancer. 2023;129:1569-1578.
    >> Share

  21. KNUDSEN MD, Wang K, Berstad P, Polychronidis G, et al
    Use of surveillance colonoscopy among individuals with removal of high-risk polyps according to the US Multi-Society Task Force recommendations.
    Cancer. 2023;129:1394-1401.
    >> Share

    April 2023
  22. CHOI DW, Kang H, Zhang HS, Jhang H, et al
    Association of polypharmacy with all-cause mortality and adverse events among elderly colorectal cancer survivors.
    Cancer. 2023 Apr 28. doi: 10.1002/cncr.34813.
    >> Share

  23. GREEN BB
    Defensive information processing and nonadherence to health-protective behaviors.
    Cancer. 2023;129:1156-1158.
    >> Share

    March 2023
    Association of physical exercise and a healthy gut microbiome in colorectal cancer.
    Cancer. 2023;129:655-656.
    >> Share

    February 2023
  25. WITMER HDD, Dhiman A, Turaga KK
    Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
    Cancer. 2023;129:495-502.
    >> Share

  26. CLARKE N, Hayes L, McQueen A, Gallagher P, et al
    The role of defensive information processing in population-based colorectal cancer screening uptake.
    Cancer. 2023 Feb 6. doi: 10.1002/cncr.34603.
    >> Share

    Colonoscopy remains the gold standard for screening despite recent tarnish: Although a recent study seemed to indicate that colonoscopies are not as effective as once thought at detecting colorectal cancer, a closer look at the study clears the confus
    Cancer. 2023;129:330-331.
    >> Share

    January 2023
  28. HAN L, Boyle JM, Walker K, Kuryba A, et al
    Impact of patient choice and hospital competition on patient outcomes after rectal cancer surgery: A national population-based study.
    Cancer. 2023;129:130-141.
    >> Share

    September 2022

  29. Screening before age 50 years can significantly reduce women's colorectal cancer incidence.
    Cancer. 2022;128:3276-3277.
    >> Share

  30. SNYDER RA, Hu CY, DiBrito SR, Chang GJ, et al
    Association of Medicaid expansion with racial disparities in cancer stage at presentation.
    Cancer. 2022;128:3340-3351.
    >> Share

  31. GANZ PA, Hays RD, Spritzer KL, Rogatko A, et al
    Health-related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R-04.
    Cancer. 2022;128:3233-3242.
    >> Share

    August 2022
  32. RIEDEL RF, Agulnik M
    Evolving strategies for management of desmoid tumor.
    Cancer. 2022;128:3027-3040.
    >> Share

    July 2022
  33. DWYER AJ, Weltzien ES, Harty NM, LeGrice KE, et al
    What makes for successful patient navigation implementation in cancer prevention and screening programs using an evaluation and sustainability framework.
    Cancer. 2022;128 Suppl 13:2636-2648.
    >> Share

    June 2022
  34. BHUTIANI N, Peacock O, Chang GJ
    A practical framework for the targeted use of total neoadjuvant therapy for rectal cancer.
    Cancer. 2022;128:2064-2072.
    >> Share

  35. JOUNG RH, Nelson H, Mullett TW, Kurtzman SH, et al
    A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Cancer. 2022;128:2119-2125.
    >> Share

    May 2022
  36. O'ROURKE K
    Periodontal disease linked to an increase in colorectal cancer.
    Cancer. 2022;128:1723.
    >> Share

    March 2022
  37. SALTZ LB
    Top advances of the year in colorectal cancer.
    Cancer. 2022 Mar 24. doi: 10.1002/cncr.34185.
    >> Share

  38. PEDERSEN SK, Musher BL, LaPointe LC, Tuck MK, et al
    Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1.
    Cancer. 2022 Mar 15. doi: 10.1002/cncr.34159.
    >> Share

  39. LEBECK LEE CM, Ziogas IA, Agarwal R, Alexopoulos SP, et al
    A contemporary systematic review on liver transplantation for unresectable liver metastases of colorectal cancer.
    Cancer. 2022 Mar 14. doi: 10.1002/cncr.34170.
    >> Share

  40. KOROUKIAN SM, Zhou G, Navale SM, Schiltz NK, et al
    Excess cancer prevalence in men with HIV: A nationwide analysis of Medicaid data.
    Cancer. 2022 Mar 14. doi: 10.1002/cncr.34166.
    >> Share

    February 2022
  41. WINKLER CS, Hardaway JC, Ceyhan ME, Espat NJ, et al
    Decreasing colorectal cancer screening disparities: A culturally tailored patient navigation program for Hispanic patients.
    Cancer. 2022 Feb 7. doi: 10.1002/cncr.34112.
    >> Share

    January 2022
  42. SELMOUNI F, Amrani L, Sauvaget C, Bakkar M, et al
    Delivering colorectal cancer screening integrated with primary health care services in Morocco: Lessons learned from a demonstration project.
    Cancer. 2022 Jan 5. doi: 10.1002/cncr.34061.
    >> Share

    Sustainable infrastructure and risk stratification are needed to appropriately deliver colorectal cancer screening globally.
    Cancer. 2022 Jan 5. doi: 10.1002/cncr.34059.
    >> Share

    December 2021
  44. CONWAY RE, Rigler FV, Croker HA, Lally PJ, et al
    Dietary supplement use by individuals living with and beyond breast, prostate, and colorectal cancer: A cross-sectional survey.
    Cancer. 2021 Dec 20. doi: 10.1002/cncr.34055.
    >> Share

  45. ANTILL Y, Buchanan DD, Scott CL
    Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer.
    Cancer. 2021 Dec 7. doi: 10.1002/cncr.34024.
    >> Share

    November 2021
  46. JAVIER-DESLOGES J, Nelson TJ, Murphy JD, McKay RR, et al
    Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
    Cancer. 2021 Nov 22. doi: 10.1002/cncr.33991.
    >> Share

  47. TRAN TT, Gunathilake M, Lee J, Kim J, et al
    Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
    Cancer. 2021 Nov 11. doi: 10.1002/cncr.34027.
    >> Share

  48. TCHELEBI LT, Shen B, Wang M, Gusani NJ, et al
    Impact of radiation therapy facility volume on survival in patients with cancer.
    Cancer. 2021;127:4081-4090.
    >> Share

    October 2021
  49. BENSON AB 3RD, Carlos RC
    Clinical trials as a path toward equity.
    Cancer. 2021;127:3717-3719.
    >> Share

    September 2021
  50. BALDWIN LM, Coronado GD, West II, Schwartz MR, et al
    Health plan-based mailed fecal testing for colorectal cancer screening among dual-eligible Medicaid/Medicare enrollees: Outcomes of 2 program models.
    Cancer. 2021 Sep 29. doi: 10.1002/cncr.33909.
    >> Share

    May 2021
  51. KIM SR, Tone A, Kim RH, Cesari M, et al
    Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.
    Cancer. 2021 May 13. doi: 10.1002/cncr.33625.
    >> Share

    April 2021
  52. BUTLER SS, Mahal BA, Moslehi JJ, Nohria A, et al
    Risk of cardiovascular mortality with androgen deprivation therapy in prostate cancer: A secondary analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Controlled Trial.
    Cancer. 2021 Apr 27. doi: 10.1002/cncr.33486.
    >> Share

    March 2021
  53. BALACHANDRA S, Kusin SB, Lee R, Blackwell JM, et al
    Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.
    Cancer. 2021;127:850-864.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016